Finance entity
markets accounts for 4 of the 6 tracked stories, while 1 other category carries the remainder. Sentiment skews less negative than the wider beat, at 0% negative against 25% across all 2568 Finance stories in the same window. HC Wainwright is most often covered alongside Wall Street Zen, which appears in 2 of these 6 stories.
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets accounts for 4 of the 6 tracked stories, while 1 other category carries the remainder. Sentiment skews less negative than the wider beat, at 0% negative against 25% across all 2568 Finance stories in the same window. HC Wainwright is most often covered alongside Wall Street Zen, which appears in 2 of these 6 stories. The 5 average consequence score is below the beat benchmark of 6.2 in the same window. Source depth averages 2 original sources per story, versus 2.8 across the same-window beat baseline. The 169-day window averages about 0.2 stories each week. HC Wainwright appears in 6 tracked Finance stories published from March 16, 2026 through August 31, 2026.
Computed from the 6 stories linked to this entity, with beat comparisons drawn from all 2568 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering HC Wainwright. Shared-story counts are live from our verified record — not editorial picks.
IREN's 15% weekly slide looks like a reaction to legacy crypto mining revenue declines rather than a rejection of its AI cloud trajectory. With $4 billion in secured annualized run-rate revenue and sold-out 2026 capacity, the selloff may be a valuation reset for patient investors.
Two micro-caps reported late-August earnings: biotech I-Mab posted $(0.16) EPS while CreditRiskMonitor posted $(0.04) EPS on $5.17M revenue. Divergent risk profiles—1.47 beta vs 0.22 beta—highlight small-cap earnings dynamics.
Halozyme Therapeutics posted a massive Q2 beat and raised FY2026 EPS guidance to $8.65-$9.00, well above the $8.02 consensus, triggering a two-day stock surge past $103. With a forward P/E near 11.5x and a PEG ratio of 0.36, the market is repricing the stock after realizing the royalty growth was underestimated.
Wall Street Zen’s hold upgrade caps a series of mixed analyst actions on Talphera, whose stock trades at $1.41 despite a $3.00 average target. Institutional positioning and a technical breakout suggest the market may be repricing a depressed small-cap. For investors, the gap represents both a unique opportunity and a cautionary tale of biotech volatility.
HC Wainwright and Needham lowered price targets on Circle Internet Group but maintained Buy ratings as analysts remain split on the stablecoin issuer. The stock trades at $63.48, far below the consensus target of $100.06, highlighting both opportunity and risk.
Flight Deck Capital has initiated a significant $10 million position in Hut 8 Corp., signaling institutional confidence in the miner's diversified infrastructure strategy. This move comes as the company navigates recent stock price volatility while aggressively expanding its high-performance computing and AI-ready data center footprint.
Source: fool.com · finance.yahoo.com
HC Wainwright is linked from 6 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
